Outcomes4Me Secures $21M in Funding Learn more >>

If your family’s story includes breast or ovarian cancer, you’re likely wondering what that means for your own health. You don’t have to guess. This is where genetic testing for ovarian cancer provides real answers. A gene test for hereditary breast and ovarian cancer can fill in the missing chapters of your family’s health story, giving you a clear picture of your inherited risk. This knowledge is powerful. It helps you and your doctor make proactive decisions. Plus, the information you learn can be a vital gift for your relatives, too.

View your personalized treatment plan in the Outcomes4Me app

Use your diagnosis to unlock personalized NCCN Guidelines®-aligned recommendations.

Continue in app

Key Takeaways

What is Genetic Testing for Breast and Ovarian Cancer?

If you or a loved one has been diagnosed with breast or ovarian cancer, you’ve probably heard the term “genetic testing.” It sounds complex, but the idea behind it is straightforward. Genetic testing is a way to look closely at your DNA for specific, inherited changes (often called mutations) that can increase your risk for developing certain types of cancer. Think of it as getting a personalized look at your body’s instruction manual to see if there are any typos that might affect your health down the line.

This kind of testing isn’t a cancer diagnosis. Instead, it’s a powerful tool that gives you and your doctor information about your personal risk factors. Understanding your genetic makeup can help you make more informed decisions about your health, from screening schedules to treatment plans. It can also provide valuable insights for your family members.

Why Genetic Testing is Crucial for Ovarian Cancer

The Challenge of Early Detection

Genetic testing is particularly important for ovarian cancer because, frankly, there isn’t a reliable screening test for early detection. Unlike mammograms for breast cancer, there’s no routine exam that can consistently find ovarian cancer in its beginning stages, when it’s most treatable. This is a huge challenge for both patients and doctors. The Ovarian Cancer Research Alliance (OCRA) emphasizes this point, noting that understanding your genetic risk can be a literal lifesaver. When you can’t rely on standard screening, knowing if you carry a gene mutation that increases your risk gives you the power to take proactive steps with your healthcare team, creating a monitoring plan that’s right for you.

Ovarian Cancer by the Numbers

The numbers really tell the story of why this is so critical. Worldwide, about 295,000 women are diagnosed with ovarian cancer each year. What’s especially striking is how many of these cases have a genetic link. Research shows that a surprisingly high number of ovarian cancers—about 1 out of every 4 or 5 cases—are caused by inherited gene changes, not just random chance. For women with specific mutations, like BRCA1 or BRCA2, the lifetime risk of developing ovarian cancer can be as high as 50%, according to the Society of Gynecologic Oncology (SGO). This information is not only vital for your own health plan but can also be incredibly important for your relatives, who may share the same genetic risks.

Why BRCA1 and BRCA2 Genes Matter

You may have heard of the BRCA1 and BRCA2 genes. These genes are some of the most well-known when it comes to hereditary breast and ovarian cancer risk. Everyone has BRCA1 and BRCA2 genes, and their job is incredibly important—they act like your body’s internal repair crew. They produce proteins that help fix damaged DNA and prevent cells from growing and dividing uncontrollably.

When one of these genes has a harmful mutation, it’s like a key member of the repair crew can’t do their job correctly. This breakdown in DNA repair can allow cells to develop genetic errors that may lead to cancer. Having a mutation in either the BRCA1 or BRCA2 gene significantly increases your lifetime risk of developing breast, ovarian, and other cancers. That’s why BRCA testing is often a starting point for understanding hereditary cancer risk.

What Are Multigene Panel Tests?

While BRCA1 and BRCA2 are major players, they aren’t the only genes linked to hereditary cancer. As our understanding of genetics has grown, so have our testing options. Today, it’s common for doctors to recommend a multigene panel test. Instead of just looking at one or two genes, these panels cast a wider net, simultaneously checking for mutations in many different genes associated with cancer risk.

Think of it this way: if a BRCA-only test is like looking for a specific book in a library, a multigene panel is like scanning an entire section for relevant titles. This approach provides a more complete picture of your potential hereditary risk. The CDC explains that these panels can identify mutations in other important genes that might have otherwise been missed, giving you and your care team a fuller understanding of your genetic profile.

Beyond BRCA: Other Genes and Syndromes to Know

Genes Associated with Lynch Syndrome

Lynch syndrome, also known as hereditary nonpolyposis colorectal cancer (HNPCC), is another important genetic condition to be aware of. While its name points to colorectal cancer, it also significantly increases the risk for endometrial, ovarian, and other cancers. This syndrome is linked to mutations in specific genes—most commonly MLH1, MSH2, MSH6, and PMS2. These genes are part of your body’s DNA spell-checking system, responsible for fixing errors when cells divide. When one of them has a mutation, mistakes can build up in your DNA, which can eventually lead to cancer.

It’s surprising to learn just how many ovarian cancer cases are hereditary. Research shows that about one in every four or five cases is caused by an inherited gene change, not just by random chance. This is why looking beyond BRCA is so critical. Identifying mutations linked to conditions like Lynch syndrome provides you and your family with crucial information. It allows you to shift from a reactive to a proactive approach, creating a personalized plan for screenings and risk-reducing strategies. This knowledge empowers you to take control of your health narrative and make decisions that are right for you.

Because of this strong connection, experts are changing their recommendations for testing. The Society of Gynecologic Oncology (SGO) now advises that all women diagnosed with ovarian, fallopian tube, or peritoneal cancer should be offered genetic counseling and testing, even if they don’t have a known family history of cancer. This is a big step forward because it acknowledges that family history doesn’t always tell the whole story. Getting a clear picture of your genetic background is essential for informing your health decisions and creating a care plan that truly fits your needs.

How Gene Mutations Affect Your Cancer Risk

Receiving a positive result from a genetic test can feel overwhelming, so it’s important to understand what it actually means. A positive result indicates that you have a gene mutation known to increase cancer risk. However, it is not a guarantee that you will get cancer. It simply means your risk is higher than that of the general population. This knowledge empowers you to take proactive steps to manage your health.

Your genetic information also has implications for your family. If you have a specific gene mutation, your first-degree relatives—your parents, siblings, and children—each have a 50% chance of carrying that same mutation. This is why your results can be a catalyst for important family conversations about health. A BRCA gene test, for example, can help your relatives understand their own risk and make informed choices about their health screenings.

Understanding Your Lifetime Risk

A big reason people consider genetic testing is to understand their lifetime risk for breast and ovarian cancer, especially if these diseases run in their family. It helps put a real number to what “higher risk” actually means. For instance, mutations in the BRCA1 and BRCA2 genes are known to significantly increase risk. According to research on genetic testing practices in ovarian cancer, women with a BRCA1 mutation have about a 44% lifetime risk of developing the disease, while those with a BRCA2 mutation have a 17% risk. When you compare that to the approximately 1% risk in the general population, you can see why this information is so important.

It’s completely normal to feel anxious about what the results might say, but it’s important to remember that a positive result doesn’t mean you will definitely develop cancer. As we explain in our guide on what genetic testing is, it simply means your risk is higher than average. This knowledge is powerful because it moves you from a place of uncertainty to one where you can take action. It allows you to work with your doctor on a personalized plan for screenings and risk-reducing strategies that are right for you.

Your genetic story is often a shared one. If you test positive for a gene mutation, your first-degree relatives—your parents, siblings, and children—each have a 50% chance of carrying the same mutation. The CDC highlights the importance of this information for families. Sharing your results can be a difficult conversation, but it gives your loved ones the opportunity to understand their own potential risk and make informed decisions about their health, too.

Should You Consider Genetic Testing?

Deciding whether to get genetic testing is a personal choice, but it’s one you don’t have to make in the dark. Certain factors in your personal and family health history can act as signposts, suggesting that a conversation with your doctor or a genetic counselor might be a good next step. Think of it as gathering all the pieces of your unique health puzzle. Looking at your family history, your own health journey, and even your ancestry can help you and your care team decide if genetic testing is right for you.

Universal Testing for Ovarian Cancer Patients

If you have an ovarian cancer diagnosis, one of the most important things to know is that genetic testing is recommended for you. This isn’t just a suggestion for people with a long family history of cancer—it’s a standard of care. Expert groups, including the Society of Gynecologic Oncology, make it clear that every person diagnosed with ovarian, fallopian tube, or peritoneal cancer should be offered testing. That’s because about 15% of these cancers are linked to inherited gene mutations like BRCA1 and BRCA2. Knowing your genetic status can directly shape your treatment plan and, just as importantly, it provides vital information for your relatives. The CDC highlights that your close family members have a 50% chance of carrying the same mutation, giving them the power to be proactive about their own health.

Does Your Family History Point to a Gene Test?

One of the strongest indicators for considering genetic testing is your family’s health story. If you look at your family tree and see multiple relatives who have had breast or ovarian cancer, especially at a young age, it’s a significant clue. The CDC notes that having many cases of these cancers in your family is a key reason you might be recommended for genetic testing for hereditary cancer. It’s also important to consider cancers in male relatives, like male breast cancer or prostate cancer. Talking with your family members about their health history can feel difficult, but it provides invaluable information for understanding your own potential risk.

What Your Personal Health History Reveals

Your own health journey is another critical piece of the puzzle. If you’ve been diagnosed with breast, ovarian, pancreatic, or prostate cancer, genetic testing can be particularly insightful. According to the Mayo Clinic, a personal history of these cancers is a primary reason to think about getting a BRCA gene test. The results can do more than just assess your risk for future cancers; they can also play a direct role in your current treatment plan. Knowing if a gene mutation is involved can open up targeted therapy options that may not have been considered otherwise, making it a powerful tool for you and your oncology team.

Why Your Ancestry Can Be a Factor

Where your family comes from can also influence your genetic makeup and potential cancer risk. For example, people of Ashkenazi or Eastern European Jewish descent have a higher likelihood of carrying BRCA1 and BRCA2 mutations compared to the general population. The Ovarian Cancer Research Alliance (OCRA) highlights that testing is especially important if you have this background. If you know your family has this ancestry, it’s a key factor to discuss with your doctor. Some organizations even provide resources and programs for free genetic testing to individuals who are at a higher risk due to their family history or ancestry, making it more accessible to get the answers you need.

Additional Risk Factors to Consider

Family History Beyond Breast and Ovarian Cancer

When piecing together your family’s health history, it’s helpful to look beyond just breast and ovarian cancer. Cancers like pancreatic and prostate cancer, especially when diagnosed at a young age, can also be part of a hereditary cancer pattern. The presence of these cancers in your family tree, alongside breast or ovarian cancer, can strengthen the case for considering genetic testing. The CDC emphasizes that a strong family history of related cancers is a key indicator that you might benefit from a conversation with a genetic counselor. It’s about seeing the bigger picture—each piece of information helps create a clearer understanding of your potential inherited risk.

Guidance for Men and Specific Ethnic Groups

It’s a common misconception that hereditary breast and ovarian cancer risk only affects women. Men can also carry and pass on genetic mutations like BRCA, which can increase their own risk for male breast cancer and prostate cancer. Understanding this is crucial not just for their own health, but for their children’s as well. Additionally, your ancestry plays a role. For instance, individuals of Ashkenazi Jewish descent have a higher chance of carrying BRCA1 and BRCA2 mutations. The Ovarian Cancer Research Alliance points out the importance of testing for this group. Knowing these specific risk factors helps ensure that everyone who could benefit from genetic testing has the opportunity to explore it.

What to Expect During the Genetic Testing Process

If you and your doctor decide that genetic testing is the right move, you might wonder what the process actually involves. The good news is that from your perspective, it’s quite straightforward. The journey from providing a sample to getting your results follows a clear path, and knowing the steps ahead of time can help you feel more prepared and in control. Let’s walk through what you can expect.

How Is Your Sample Collected?

The first step in the process is giving a sample for the lab to analyze. This is a simple and quick procedure. Most genetic tests require either a small blood sample, drawn from a vein in your arm, or a saliva sample, where you spit into a special tube. You can typically provide your sample at a doctor’s office, hospital, or a designated lab. Some companies even offer at-home collection kits that are mailed directly to you, which can be a convenient option. Your healthcare provider will guide you on which type of genetic test is being ordered and where you can have your sample collected.

What Happens to Your Sample at the Lab?

Once your sample arrives at the lab, specially trained technicians and scientists get to work. Their job is to carefully examine your DNA, looking for specific changes, known as mutations, in certain genes. For hereditary breast and ovarian cancer, they often focus on the BRCA1 and BRCA2 genes. In many cases, your doctor may order a multigene panel test, which is a broader approach that checks for mutations in several different genes at the same time, including BRCA1 and BRCA2. This comprehensive analysis helps create a more complete picture of your genetic makeup and potential cancer risk.

Inherited (Germline) vs. Tumor (Somatic) Testing

When you hear about genetic testing, it’s important to know there are two main types, and they serve very different purposes. The first is inherited testing, also called germline testing. This is the one that looks at the DNA you were born with—the genetic information passed down from your parents. This test identifies inherited gene mutations, like BRCA1 and BRCA2, that can affect your lifetime risk of developing cancer. Because these mutations are hereditary, the results can also be incredibly important for your relatives. The second type is tumor testing, also known as somatic testing. Instead of looking at your inherited DNA, this test analyzes the DNA from the cancer cells themselves. The goal here is to find specific mutations that have occurred only within the tumor. This information is powerful because it can help your care team identify the best targeted therapies for your specific cancer. So, while germline testing is about understanding your family’s inherited risk, somatic testing is all about personalizing your treatment plan.

When Can You Expect Your Results?

This is where a little patience comes in. Analyzing your DNA is a detailed and complex process that can’t be rushed, so it typically takes several weeks to get your results back. The exact timing can vary depending on the specific test being performed and the lab doing the analysis. Waiting can feel like the hardest part, but it’s a normal part of the process. Once the results are ready, they will be sent to your doctor or genetic counselor, who will then schedule a time to discuss them with you, explain what they mean for your health, and help you plan your next steps.

What Do My Genetic Test Results Mean?

Getting your genetic test results back can bring up a lot of emotions. Whether you feel anxious, relieved, or just plain confused, remember that this information is a tool. It’s designed to give you and your care team more clarity so you can make informed decisions about your health. Let’s walk through what the different types of results—positive, negative, and uncertain—really mean for you and your family.

Understanding a Positive Result

Receiving a positive result means the test found a specific change, or mutation, in a gene that is known to increase the risk of hereditary breast and ovarian cancers. While this news can feel heavy, it’s also incredibly powerful. This knowledge allows you to be proactive about your health. You can work with your doctor to create a plan for early detection or take steps to lower your cancer risk. If you’ve already been diagnosed with cancer, a positive result can be a key piece of the puzzle, helping to guide your treatment options and open doors to therapies targeted specifically at your cancer’s genetic makeup.

What a Negative Result Really Means

A negative result can be a huge relief, but its meaning depends on your family’s health history. If a specific gene mutation is already known to run in your family and your test comes back negative for that same mutation, it’s considered a “true negative.” This is great news, as it means your cancer risk is likely the same as the general population’s. However, if you don’t have a known family history of a specific mutation, a negative result is a bit more complex. It means you don’t have the mutations the test looked for, but it doesn’t completely rule out an increased hereditary risk. A genetic counselor can help you understand what a negative result means for you personally.

What is a “Variant of Uncertain Significance” (VUS)?

Sometimes, a genetic test will identify a gene change that hasn’t been clearly linked to cancer risk. This is called a “variant of uncertain significance,” or VUS. Hearing the word “uncertain” can be unsettling, but it simply means that researchers don’t have enough data yet to classify the variant as either harmful (positive) or harmless (negative). Think of it as a “we’ll get back to you on this” from the scientific community. As researchers gather more information, these variants are often reclassified. Your genetic counselor will explain what a VUS means for your health plan in the meantime and will let you know if its classification changes in the future.

How Your Results Can Help Your Family

Your genetic test results don’t just belong to you—they can be a vital piece of health information for your entire family. If you test positive for a gene mutation, your close biological relatives (like your parents, siblings, and children) have a 50% chance of carrying that same mutation. Sharing this information with them is one of the most important steps you can take. It gives them the opportunity to pursue their own testing for that specific gene change. This knowledge can empower them to make proactive decisions about their own health and screening plans, potentially leading to early detection or prevention. It’s a conversation that can truly make a difference for the people you love.

What is Cascade Testing?

When you receive a positive genetic test result, the information is bigger than just you. This is where cascade testing comes in. It’s the process of offering genetic testing to your first-degree relatives—your parents, siblings, and children—after you’ve tested positive for a specific gene mutation. According to the Mayo Clinic, each of these relatives has a 50% chance of carrying the same mutation. Sharing this information with them is one of the most important steps you can take. It opens the door for them to get tested, understand their own risk, and make proactive choices about their health screenings and preventive care. It’s a powerful way to turn your personal health information into a collective tool for your family’s well-being.

Common Myths About Genetic Testing, Debunked

When you’re considering genetic testing, it’s easy to get tangled up in misinformation. The topic can feel complex, and there are a lot of myths floating around that create unnecessary worry. Let’s clear the air by looking at the facts behind some of the most common misconceptions about genetic testing for breast and ovarian cancer. Understanding the reality can help you feel more confident and prepared as you make decisions about your health. Getting straight answers is the first step toward taking control of your health journey.

Myth: Most Breast Cancer is Hereditary

It’s a common belief that a breast cancer diagnosis is almost always tied to family history, but that’s not the case. The truth is, most breast cancers are considered “sporadic,” meaning they happen by chance and are not linked to an inherited gene mutation. While having a strong family history of breast or ovarian cancer is a significant reason to consider genetic testing, it’s important to know that only about 5% to 10% of all breast cancers are thought to be hereditary. This is why understanding your personal risk factors, in addition to your family’s health history, is so crucial for you and your care team.

Myth: A Genetic Test Gives a Definitive Answer

It would be nice if every test gave a simple “yes” or “no” answer, but genetic testing can sometimes be more complex. While many people get a clear positive or negative result, some receive a “variant of uncertain significance” (VUS). This means the lab found a change in one of your genes, but experts don’t yet know if that specific change affects your cancer risk. It’s an ambiguous result that can be frustrating, but it’s important to know it’s a possibility. Additionally, it’s helpful to remember that genes like BRCA1 and BRCA2 are linked to an increased risk of several cancers, including ovarian, prostate, and pancreatic cancer, not just breast cancer.

Myth: My Results Could Affect My Insurance

Many people worry that a positive genetic test result could lead to them being denied health insurance or employment. Thankfully, there are legal protections in place. The Genetic Information Nondiscrimination Act (GINA), a federal law, makes it illegal for health insurance companies and employers to discriminate against you based on your genetic information. However, it’s important to be aware that GINA’s protections do not extend to life insurance, disability insurance, or long-term care insurance. Understanding these distinctions can help you make informed decisions before you get tested.

How Genetic Testing Influences Ovarian Cancer Treatment

For anyone diagnosed with ovarian cancer, genetic testing takes on a new level of importance. It’s no longer just about understanding your future risk or informing your family members—it becomes a critical part of your immediate treatment strategy. The information hidden in your genes can directly influence which therapies your oncology team recommends, opening the door to more personalized and effective treatments. This knowledge empowers you to have more detailed conversations with your doctor about a plan that is tailored specifically to the biology of your cancer, moving beyond one-size-fits-all approaches.

Targeted Therapies: PARP Inhibitors

One of the most significant ways genetic testing impacts ovarian cancer care is by identifying who can benefit from a class of drugs called PARP inhibitors. These are a type of targeted therapy, which means they are designed to attack cancer cells with specific characteristics while largely sparing healthy cells. As research explains, PARP inhibitors work through a clever process called “synthetic lethality.” They exploit a pre-existing weakness in cancer cells that have faulty DNA repair systems, like those with a BRCA gene mutation. By blocking a second DNA repair pathway, PARP inhibitors leave the cancer cells with no way to fix themselves, causing them to die off. This targeted approach can be a highly effective treatment strategy.

The Role of Homologous Recombination Deficiency (HRD)

The story doesn’t end with BRCA mutations. Genetic testing can also look for something called Homologous Recombination Deficiency, or HRD. Think of homologous recombination as your cell’s most effective DNA repair team. When that team isn’t working correctly, the cell has HRD. This is a common feature in ovarian cancer—in fact, about half of all high-grade serous ovarian cancers have this DNA repair problem. This is important because even if you don’t have a BRCA mutation, having an HRD-positive tumor means you might still be a candidate for PARP inhibitor therapy. Testing for HRD status gives your care team a more complete picture, creating more opportunities for personalized treatment.

What Are Your Next Steps After Getting Results?

Receiving your genetic test results can bring up a lot of emotions, whether they’re positive, negative, or uncertain. Remember, this information isn’t a diagnosis—it’s a powerful tool. It gives you and your care team the knowledge to create a proactive health plan that’s tailored specifically to you. Think of your results as the first step in a conversation about your long-term health and well-being. The next steps are all about working with your doctor to understand what this information means for you and deciding on a path forward together.

Making a Plan to Manage Your Cancer Risk

If you test positive for a gene mutation like BRCA1 or BRCA2, your first move is to schedule a follow-up with your doctor and a genetic counselor. They are your partners in this process and will help you understand the results in the context of your personal and family health history. Together, you can create a clear plan to lower your cancer risk. This plan might include more frequent cancer screenings, such as alternating between mammograms and breast MRIs. It’s also a good time to discuss whether your close relatives, like siblings and children, should consider getting tested, as they may share the same genetic risk.

Is Preventive Surgery Right for You?

For some people with a positive result, preventive (or prophylactic) surgery is an option to consider. This involves surgically removing healthy tissue to significantly reduce the chance of cancer developing. The most common procedures are a prophylactic mastectomy (removal of breast tissue) and a salpingo-oophorectomy (removal of ovaries and fallopian tubes). This is a very personal decision with physical and emotional implications, and it’s not the right choice for everyone. Your healthcare team can walk you through the benefits and risks, helping you weigh this option against other risk-management strategies like enhanced screening or medication.

Recommended Timing for Preventive Surgery

If you’re considering preventive surgery, you might be wondering, “When is the right time?” The answer often depends on the specific gene mutation you carry. For women with a BRCA1 mutation, experts often recommend considering the removal of ovaries and fallopian tubes (a procedure called a bilateral salpingo-oophorectomy, or BSO) between the ages of 35 and 40. For those with a BRCA2 mutation, the recommended window is typically between 40 and 45. This timing is based on when cancer risk begins to significantly increase, and studies show this surgery can reduce ovarian cancer risk by up to 96%. Ultimately, this is a deeply personal decision with long-term implications for your body and your life. It’s essential to have an open conversation with your care team to explore all your options and decide on a timeline that feels right for you.

How to Create Your Personal Screening Plan

Based on your results, your healthcare team will help you create a personalized screening schedule. This isn’t a one-size-fits-all plan; it’s designed just for you. For example, instead of starting mammograms at age 40, your doctor might recommend starting them earlier or having them more often. They might also add other imaging tests, like breast MRIs, to your routine. The goal is to catch any potential issues as early as possible. Your doctor can also discuss other ways to lower your risk, such as medications that can reduce the chances of developing certain cancers. This personalized BRCA gene test plan puts you in control of your health monitoring.

How to Partner With Your Doctor on Next Steps

Ultimately, knowing your genetic status helps you and your doctor become stronger partners in managing your health. This knowledge empowers you to make truly informed choices about your care, from screenings to preventive actions. If you have already been diagnosed with cancer, this information can sometimes influence treatment decisions, as certain therapies are more effective for cancers linked to specific gene mutations. By understanding your personal risk profile, you can work collaboratively with your doctor to build a comprehensive health strategy that feels right for you and your life.

How Outcomes4Me Can Support You

Receiving your genetic test results can bring a mix of emotions and a lot of questions. Whether you’re feeling relieved, anxious, or just plain overwhelmed, having a trusted resource can make all the difference. The Outcomes4Me app is designed to be that resource for you, helping you understand your results and what they mean for your health journey. We translate complex medical information into clear, actionable steps so you feel informed and in control. Think of us as your personal guide, here to help you process this new information and partner with your care team to create a plan that’s right for you.

Get Personalized, Evidence-Based Guidance

Your genetic test results are unique to you, and your follow-up plan should be, too. The Outcomes4Me app helps you make sense of what your results mean by providing personalized information based on the latest evidence-based guidelines. We break down the medical jargon so you can clearly understand your specific situation. Genetic testing provides crucial information that can guide your healthcare decisions, and our platform ensures that guidance is tailored to your diagnosis, genetic markers, and health history. We put the power of information in your hands, helping you understand your options and feel more confident as you move forward with your health plan.

Find Treatment Options and Clinical Trials for You

Knowing your genetic status can open up new avenues for managing your health. If you test positive for a gene mutation like BRCA, your healthcare team will help you make a plan for more frequent screenings or discuss ways to lower your risk. The Outcomes4Me app can help you explore these possibilities by matching you with relevant treatment options, preventive measures, and even clinical trials based on your unique profile. We sift through the vast amount of information out there to bring you options that are specific to your situation, saving you time and reducing the stress of research. This allows you to have more informed discussions with your doctor about the proactive steps you can take.

Connect Seamlessly with Your Care Team

Having productive conversations with your doctors is key to managing your health, and we’re here to help you prepare. The app provides tools to track your health, manage your records, and organize your questions, so you can walk into every appointment feeling ready. Experts agree that genetic counseling is an important part of the process, helping you and your family understand your results and make decisions. Outcomes4Me serves as a bridge, helping you organize the information you receive from your genetic counselor and doctor. By keeping all your health data in one secure place, you can easily share updates and collaborate with your care team to ensure everyone is on the same page.

Related Articles

View your personalized treatment plan in the Outcomes4Me app

Use your diagnosis to unlock personalized NCCN Guidelines®-aligned recommendations.

Continue in app

Frequently Asked Questions

If I test negative, does that mean I’m completely in the clear for breast or ovarian cancer? A negative result is definitely reassuring, but it’s not a free pass. It means you don’t carry the specific harmful gene mutations the test was looking for. This is great news, especially if a known mutation runs in your family. However, most cancers are not hereditary. Your overall risk is still influenced by other factors like lifestyle and environment, so it’s important to continue with regular screenings and maintain a strong partnership with your doctor to monitor your health.

What’s the real difference between a multigene panel and a test that only looks for BRCA mutations? Think of it like this: a BRCA-only test is looking for two very specific, well-known risk factors. A multigene panel casts a wider net. It checks for mutations in the BRCA genes plus a number of other genes that have also been linked to an increased cancer risk. Your doctor might recommend a panel test to get a more complete picture of your potential hereditary risk, as it can sometimes find answers that a more targeted test might miss.

How do I bring up genetic testing with my doctor without feeling like I’m overreacting? This is a completely valid concern, but remember, you are your own best health advocate. You can start the conversation simply by saying something like, “I’ve been thinking about my family’s health history, and I’d like to talk about whether genetic testing might be right for me.” You can also mention specific concerns, such as a relative’s diagnosis or your ancestry. This isn’t overreacting; it’s being proactive and informed, and your doctor will see it as a responsible step.

My family isn’t open about their health history. Can I still get tested? Yes, absolutely. While a detailed family history is incredibly helpful, it’s not the only reason to consider testing. Your own personal health history, such as a cancer diagnosis at a young age, or your ancestry can be strong enough indicators on their own. Share what you do know with your doctor or a genetic counselor. They can help you determine if testing is appropriate based on the information you have.

What exactly does a genetic counselor do, and why is talking to one so important? A genetic counselor is an expert who acts as your translator and guide through this entire process. Before you even get tested, they can help you decide if it’s the right choice for you. Afterward, they do much more than just give you the results. They help you understand what the results truly mean for your health and for your family, discuss the emotional side of things, and walk you through all of your options for managing your health moving forward.